For the Inventor, By the Inventor

Enter assignee name

Milford, MA, United States of America

Reprieve Cardiovascular, Inc.

USPTO Granted Patents = 17

EPO Patents = 1

Trademarks = 2

Forward Citations = 58

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Andrew Victor Halpert (17 out of 41 patents)

Jeffrey Testani (7 out of 7 patents)

Antony Jonathan Fields (7 out of 45 patents)

4. Eric Conley (5 out of 7 patents)

5. Howard R Levin (5 out of 131 patents)

6. Mark Gelfand (4 out of 216 patents)

7. Jim Dillon (4 out of 4 patents)

8. Mark Tauscher (4 out of 13 patents)

9. Kenneth John Luppi (4 out of 5 patents)

10. Howard Levin (3 out of 52 patents)

11. Wieslaw Gronek (2 out of 4 patents)

12. Robert I Rudko (2 out of 36 patents)

13. Mark Richard Pacyna (2 out of 2 patents)

14. Zoar Engelman (2 out of 2 patents)

15. Megha Shah (2 out of 2 patents)

17 patents: Sort by Forward Citations

1. 12741092 - Fluid therapy based on estimated excess fluid, and associated systems and methods (2026-09-22),

2. 12605702 - Measuring and/or detecting analytes in urine, and associated systems, devices, and methods (2026-04-21),

3. 12582773 - Urine output sensing without use of an indwelling catheter, and associated systems, devices, and methods (2026-03-24),

4. 12471842 - Fluid therapy based on adjusted urine output rate, and associated systems, devices, and methods (2025-11-18),

5. 12303271 - Urine collection systems and associated methods and devices (2025-05-20),

6. 12290380 - Method and system to monitor urine output and manage fluid retention in a patient (2025-05-06),

7. 12257416 - Fluid therapy based on sodium excretion, and associated systems, devices, and methods (2025-03-25),

8. 12239819 - Method and system to treat acute decompensated heart failure (2025-03-04),

9. 11992332 - Fluid replacement device (2024-05-28),

10. 11986302 - Urine collection systems and associated methods and devices (2024-05-21),

11. 11950925 - Managing fluid levels in a patient and associated devices, systems, and methods (2024-04-09),

12. 11696985 - Fluid therapy method (2023-07-11),

13. 11633137 - Urine collection systems and associated methods and devices (2023-04-25),

14. 11627912 - Managing fluid levels in a patient and associated devices, systems, and methods (2023-04-18),

15. 11357446 - Managing fluid levels in a patient and associated devices, systems, and methods (2022-06-14),

Company Overview

Reprieve Cardiovascular, Inc. is a medical technology company based in Milford, MA, specializing in innovative solutions for cardiovascular health. The organization focuses on developing advanced medical devices and therapies aimed at improving patient outcomes in the treatment of heart-related conditions. By leveraging cutting-edge research and technology, Reprieve Cardiovascular seeks to address critical challenges in cardiovascular care, enhancing the quality of life for patients and advancing the field of cardiology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

17 Patents

#10 in Milford, MA

#1,151 in Massachusetts

#18,903 in US

#35,948 in the World

Milford, MA, United States of America

Reprieve Cardiovascular, Inc.

Forward Citations = 58

19 inventors:

Andrew Victor Halpert (17 out of 41 patents)

Jeffrey Testani (7 out of 7 patents)

Antony Jonathan Fields (7 out of 45 patents)

4. Eric Conley (5 out of 7 patents)

5. Howard R Levin (5 out of 131 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Reprieve Cardiovascular, Inc.. Retrieved from https://idiyas.com/company/reprieve-cardiovascular

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…